[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="USA" width="100%" palette="financial-light"]

Food & Health

hog margin collapse illustration
Smithfield Faces Pork Segment Loss Amid Margin Collapse
Smithfield Foods (SFD.O) shares fell nearly 2% in extended trading on Tuesday after the pork giant said its fresh pork segment will swing to an adjusted operating loss in Q3, a sharp reversal that underscores deepening margin pressure across the U.S. protein sector. The guidance...
biotech consolidation illustration
Novartis Faces Setbacks in Pipeline Tension
A neuromuscular drug candidate acquired through Novartis’s (NVS) $12 billion Avidity Biosciences...
Ionis Secures FDA Nod for First Alexander Therapy
Ionis Pharmaceuticals (IONS.O) secured the first FDA approval for Alexander disease on Thursday, with analysts projecting the injectable therapy could...
Novartis Faces CAR-T Challenges in Autoimmune Trials
JBS Billionaire Spurs Shift in U.S. Beef Tariffs
J&J's Imaavy: A Breakthrough in Rare Blood Disorder
Regenxbio Slump: Spine Nodules Halt Therapy Trial
Guardant Health's $245M Patent Setback & Its Implications
gilead ouro deal illustration
Regeneron's Pasatru Enters Ultra-Rare Bone Market
Regeneron Pharmaceuticals (REGN.O) surged 4% Wednesday after the FDA approved Pasatru for a bone-hardening disorder, adding a second approved rival to Ipsen’s Sohonos in...
Pilgrim's Pride buyout impact illustration
JBS Eyes Full Control: Pilgrim's Pride Buyout Impact
JBS (JBSS3.SA), the world’s largest meatpacker, proposed Monday to acquire the roughly 18% of Pilgrim’s Pride (PPC) it does not already own, a move that would consolidate...
biotech consolidation illustration
Hilleman Bios Boosts Congo Vaccine Drive Amid Crisis
Hilleman Laboratories, the Singapore-based Merck (MRK) and Wellcome joint venture, is manufacturing an experimental Bundibugyo-strain Ebola vaccine for clinical trials as Congo’s...
TAVR sales growth Q2 illustration
Edwards Lifesciences' TAVR Sales Propel Q2 Success
Edwards Lifesciences (EW) surged nearly 7% in after-hours trade on July 23 after second-quarter revenue of $1.74 billion and adjusted earnings of $0.78 per share both cleared Wall...
gilead ouro deal illustration
Roche's CER Growth Outshines Swiss Franc Impact
Roche Holding (ROG.SW) confirmed its full-year guidance after first-half sales grew 6% at constant exchange rates, beating analyst consensus and underscoring the Swiss drugmaker’s...
MORE NEWS
Platinum Equity JV illustration
Nestlé and Platinum Equity Forge Waters JV Deal
gilead ouro deal illustration
Novartis Boosts Profits Amid Generic Challenges
gilead ouro deal illustration
Samsung Expects Growth with $1.8B PolyPeptide Deal
CATEGORIES